Search results

{{r|Atherosclerosis}}

...cholesterol ''carried by'' low-density lipoproteins (LDL) tend to increase atherosclerosis while [[HDL cholesterol|cholesterol carried by high-density lipoproteins]]

...[[myocardial infarction|heart attacks]] and [[stroke]]s, and to diminish [[atherosclerosis|arterial plaque]] formation. It is used to reduce levels of total choleste

...s Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes: The SANDS (Stop Atherosclerosis in Native Diabetics Study) Trial | journal = J Am Coll Cardiol | accessdate

...yocardial infarction|heart attacks]] and strokes by diminishing coronary [[atherosclerosis]]. It functions by inhibiting [[3-hydroxy-3-methylglutaryl coenzyme A redu

...rction|heart attacks]] and [[stroke]]s, and to diminish the formation of [[atherosclerosis|arterial plaque]]. Baycol was voluntarily removed from the U.S. market in

...rction|heart attacks]] and [[stroke]]s, and to diminish the formation of [[atherosclerosis|arterial plaque]]. It is a [[Hydroxymethylglutaryl-coenzyme A reductase in

...008). Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial

...l / [[HDL cholesterol]] in determining risk of [[vascular disease]] from [[atherosclerosis]].<ref name="pmid19903920">{{cite journal| author=Emerging Risk Factors Col

...farction|heart attacks]] and [[stroke]]s, and to lessen the formation of [[atherosclerosis|artial plaque]]. It is a [[Hydroxymethylglutaryl-coenzyme A reductase inhi

...roup, found "in patients with angiographically proven symptomatic coronary atherosclerosis, alpha-tocopherol treatment substantially reduces the rate of non-fatal MI, ...ormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial |journal=JAMA |volum

...eart or brain but cannot eliminate our vulnerabilities to nearsightedness, atherosclerosis, depression, or cancer. Darwinian Medicine applies the advances that have r

===Predicting risk of atherosclerosis=== ...ntly healthy people due to the theory that chronic inflammation precedes [[atherosclerosis]].<ref name="pmid16818927">Lloyd-Jones DM, Liu K, Tian L, Greenland P. [htt

...arteriosclerosis]] in the arteries of the lower extremities usually from [[atherosclerosis]].

...ls to address two of the largest medical problems in developed countries — atherosclerosis and obesity.''

...in structures of the nervous system; [[ischemia]] caused by [[thrombi]], [[atherosclerosis]] and other interference with blood flow including congenital narrowing; an

...m the obesity-related abnormalities that promote [[insulin resistance]], [[atherosclerosis]] and [[Type 2 Diabetes Mellitus]]. This phenotype is termed ‘Metabolical • Compared to obese: lower risk of atherosclerosis due to decreased carotid IMT levels

...A, Zanchetti A| title=Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. | journal=J Hypertens | year= 1997 | volume= 15

...owing or occlusion of the renal artery or arteries. It is due usually to [[atherosclerosis]]; fibromuscular dysplasia; [[thrombosis]]; embolism, or external pressure. ...son<ref name="Richardson">{{cite journal |author=Richardson GO et al|title=Atherosclerosis of the main renal arteries in essential hypertension |journal=The Journal o

*{{CZ:Ref:Shively 2009 Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation}}